OOIR: Observatory of International Research

Papers

(The TQCC of European Journal of Hospital Pharmacy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings	66
Medicines Delivery Proximity Programme (PEMProxi) survey results	45
Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease	24
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients	24
Medicine shortages in France: a 6-year retrospective study in a university medical centre	20
Medical device resources for hospital pharmacists	16
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years	14
Medication stability: from pharmacies to patients’ homes—is consistent storage achievable?	14
Advanced therapy medicinal products	14
Broad perspective on the relationship between soticlestat and QT interval in patients with epilepsy	13
Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent	12
Implementation and effectiveness of pharmacist-led interviews at patient hospital admission in a rheumatology department	11
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations	11
Medication safety strategies in European adult, paediatric, and neonatal intensive care units: a cross-sectional survey	11
Evaluation of inappropriate antibiotic prescribing and management through pharmacist-led antimicrobial stewardship programmes: a meta-analysis of evidence	11
Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study	11
Empowering European hospital pharmacists in the face of heart failure	10
Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology	10
The threatened medicines information pharmacist!	10
Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin’s lymphoma: a case report	9
Design and validation of a predictive equation to estimate unbound valproic acid concentration	9
Optimisation of the quality of care for patients with severe asthma: ASfarMA project	8
EJHP’s impact factor moves on up	8
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze	8
Development and validation of a feasible questionnaire to assess pharmacists’ attitudes to documenting and classifying pharmaceutical interventions in hospital settings	7

Cost-effectiveness of preoperative pharmaceutical care consultations: a 5-year analysis	7
Antifungal prophylaxis against invasiveCandidaandAspergillusinfection in adult heart transplant recipients: protocol for a systematic review and meta-analysis	7
Benefits of using a microencapsulated vitamin D delivery system in women with polycystic ovary syndrome	6
EMA guidance for industry to prevent and mitigate medicine shortages	6
Hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction: a case report	6
EAHP’s special interest group on hospital pharmacist’s preparedness for in-vivo GTMP publishes report	6
A retrospective hospital benefit and cost analysis of the management of human tissues for orthopaedic allografts	6
Thoughts on the shortage of vinflunine: could we have done more?	6
The end of an era!	6
Beta-lactam allergy in patients: an antibiotic stewardship challenge	6
¹⁷⁷Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods	6
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence	5
Long-term stability of esketamine in polypropylene syringes at 5 ± 3°C	5
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients	5
EAHP’s COVID-19 Report showcases the contributions of hospital pharmacists and shares recommendations	5
Show how you keep antibiotics working during this year’s EAAD	5
Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort	5
Evaluation of statin-induced muscle and liver adverse drug reactions in the Chinese population: a retrospective analysis of clinical trial data from 1992 to 2023	5
Inhaled aztreonam lysine in the management ofPseudomonas aeruginosain patients with cystic fibrosis: real-life effectiveness	5
Colchicine–enzalutamide interaction: clinical implications and multi-disciplinary management	4
The importance of authorship integrity in scientific publications within healthcare and hospital pharmacy	4
A collaborative telepharmacy model for dispensing and informed delivery from hospital to community pharmacies	4
Pancytopenia in a patient treated with fusidic acid and niraparib: a case report	4
Penicillin allergy that persisted after 66 years: case report	4
Risk factors for unintentional medication discrepancies identified through pharmacy staff-led medication reconciliation to prioritise patients in the emergency department: a rapid review	4
Medical management of first trimester miscarriage: a quality improvement initiative	4
Haemolytic anaemia induced by flutamide: a case report	4
Women and adverse drug reactions: 56 years of analysis of real-world data collected in the FDA adverse event reporting system (FAERS) database	4
Digitalisation of the drug prescribing process in Swiss hospitals – results of a survey	4
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time	4
Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report	4
Clinical trials	4
Medication adherence interventions: where are we and where do we go?	4
Switching of anti-migraine antibodies: effectiveness or regression to the mean?	3
Tocilizumab in COVID-19 management: addressing time of starting treatment	3
Cannabis hyperemesis syndrome: an emerging clinical and public health challenge	3
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document	3
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing	3
Automated preparation of cytotoxic drugs: the evidence for an interface between the robot and computerized provider order entry?	3
Capecitabine: guaranteed access in adjuvant treatment of breast cancer	3
Implementation of pharmaceutical infusion management to reduce incompatibilities and fluid overload: a retrospective observational study in a paediatric intensive care unit	3
Influence of baseline characteristics and stratification level of patients living with HIV on pharmaceutical interventions developed according to the Capacity-Motivation-Opportunity methodology	3
Study of overall survival associated with nintedanib and pirfenidone in patients with idiopathic pulmonary fibrosis: a real-life comparison	3
An antidote network in Spain, a tool to improve antidote availability in hospitals	3
Update on the hospital pharmacist profile: from clinical practice to management	3
Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports	3
Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags	3
Advanced ALK-positive lung cancer with lorlatinib versus crizotinib in Asian patients with brain metastases	3
RETRACTED: Specific features of rational pharmacotherapy in elderly patients	3
Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumab	3

Role of EMA for crises strengthened	3
Pharmacological resilience in the context of geopolitical tensions: a European perspective	3
Systematic review of room temperature stability of key beta-lactam antibiotics for extended infusions in inpatient settings	3
Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients	3
In-hospital expenditure for medical devices in relation to funds from diagnosis-related groups and ambulatory activity: temporal trend from 2019 to 2022	3
Infectious diseases and antimicrobial resistance	3
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients	3
Stability and compatibility of admixtures containing bupivacaine hydrochloride and ketorolac tromethamine for parenteral use	2
Patient safety culture and medication safety in European intensive care units: a focus group study	2
Beyond conventional dosing: tailoring antimicrobial regimens for cachexia	2
Access to medicines	2
The PEPSIN project: design and validation of a self-administered questionnaire for the assessment of equivalence between pens and prefilled syringes in patients on subcutaneous biological drugs	2
Use of simulation for education in hospital pharmaceutical technologies: a systematic review	2
Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review	2
Comparison of adverse drug reactions of statins in China from 1989 to 2019	2
Haemodynamic effects of intravenous acetaminophen in critically ill paediatric patients: a retrospective chart review	2
Antimicrobial resistance in Nigeria: challenges and charting the way forward	2
Medication-related problems in critical care survivors: a systematic review	2
A pharmacovigilance study on antiepileptic medications in a paediatric hospital in Italy	2
Improvement in RAID questionnaire results in patients with rheumatoid arthritis treated with advanced therapies	2
Drug intoxication: a silent obstacle to organ donation	2
Looking back and looking forward	2
The Granada Statements: an impact boost to clinical and social pharmacy publications, part 1	2
To maximise impact, hospital pharmacists need to increase visibility	2
Infliximab: a single-centre, prospective, observational evaluation of TDM data in patients with IBD	2
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients	2
Pharmaceutical care in the screening process of phase I oncohaematological clinical trials	2
Primary care electronic medication record discrepancies in patients starting treatment at a hospital-based ambulatory care pharmacy and impact on prevalence of potential drug–drug interactions	2
Clinical and economic benefits of expanded access programs: should we strengthen these pharmacist-led initiatives?	2
Welcome to this online edition	2
Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisation	2
Digital health	2
Introduction to an online only issue	2
Medication adherence in chronic myeloid leukemia: a hospital pharmacy-level analysis	2
Spread awareness, stop resistance – getting ready for WAAW and EAAD	2
How to manage the overwhelming amount of database-detected interactions? A focus group meeting study on the management of database-detected risks of drug interactions	2
Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-19	2
Defining a new term: defensive hospital pharmacy practices	2
Public information on shortages in the EU/EEA: improvements made between 2018 and 2020	2
European health data space proposal launched	2
Study of therapeutic patient education practices in French renal transplantation centres	2
Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy	2
Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment	2
Implementation of pharmacists’ monitoring for intravenous drug compatibility	2
Monitoring of occupational exposure to hazardous medicinal products in robotic compounding	2
Evaluation of resources for effective decision-making about drug manipulation	2
Importance of medication reconciliation, even in the absence of positive data	2
Retrospective study of plasma anti-Xa levels in renally impaired patients receiving reduced or non-reduced therapeutic doses of dalteparin	2
Sulperazon-induced acute reactive thrombocytopenia during treatment of systemic lupus erythematosus: a case report	2
Liquid antimicrobials: a national analysis of critical shortages	2
When gravimetry is debated by sponsors of clinical studies	2
Antimicrobial resistance: a major priority for global focus	2
Older people, medication usage and long-term care pharmacists: a retrospective cohort study	2
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations	2
Organisational impact of in vivo gene therapies at two French injection centres	2
Should vericiguat be initiated in geriatric inpatients with heart failure with reduced ejection fraction and a worsening heart failure event prior to discharge?	2
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series	2
Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins	2
Ceftaroline combination therapy for methicillin resistant coagulase negativeStaphylococcusbacteraemia and endocarditis	2
Assessment of particle contamination in vancomycin syringe pumps following fluid withdrawal using three diverse aseptic reconstitution techniques	2
Deep learning classification of drug-related problems from pharmaceutical interventions issued by hospital clinical pharmacists during medication prescription review: a large-scale descriptive retrosp	2
Results of EAHP’s 2023 shortages survey	2